Key Insights

Highlights

Success Rate

96% trial completion (above average)

Published Results

44 trials with published results (21%)

Research Maturity

135 completed trials (66% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

2.9%

6 terminated out of 205 trials

Success Rate

95.7%

+9.2% vs benchmark

Late-Stage Pipeline

34%

70 trials in Phase 3/4

Results Transparency

33%

44 of 135 completed with results

Key Signals

44 with results96% success

Data Visualizations

Phase Distribution

143Total
Not Applicable (59)
P 1 (1)
P 2 (13)
P 3 (13)
P 4 (57)

Trial Status

Completed135
Unknown24
Recruiting21
Not Yet Recruiting11
Terminated6
Withdrawn5

Trial Success Rate

95.7%

Benchmark: 86.5%

Based on 135 completed trials

Clinical Trials (205)

Showing 20 of 20 trials
NCT05788718Completed

An Observational Study to Analyze the Prescription Pattern of Sugammadex and Its Effectiveness and Safety

NCT07404579Phase 2RecruitingPrimary

Safety and Efficacy of HRS-9190 Compared to Rocuronium for Bolus Maintenance in Adults

NCT07478120CompletedPrimary

Muscle and Fat Mass in Preoperative Computed Tomography and a Neuromuscular Blocking Agent Dose

NCT07003061Recruiting

Sarcopenia and Neuromuscular Block in Gastrointestinal Cancer Surgery

NCT07446309Phase 2Not Yet RecruitingPrimary

Safety and Efficacy of HRS-9190 Compared to Cisatracurium for Continuous Intravenous Infusion in Adults

NCT07435792Not ApplicableNot Yet Recruiting

TetraGraph to Evaluate Onset and Recovery Times of Rocuronium

NCT07203287Phase 4Recruiting

Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease

NCT04195178CompletedPrimary

Understanding the Cognition and Decision Making of Community Anesthesiologists

NCT06220136RecruitingPrimary

Comparison of the Performances of the cTOFR and the mTOFR During Reversal of Deep Neuromuscular Blockade With Sugammadex

NCT06553131RecruitingPrimary

Median Versus Ulnar Nerve Quantitative Electromyography Neuromuscular Blockade Monitoring Comparison

NCT07252921Phase 2CompletedPrimary

Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation in Adults

NCT06948409Active Not Recruiting

NMBA Reversal and Postoperative Urinary Retention

NCT06467448Completed

Comparing Train-of-Four Recovery in the Adductor Pollicis Versus the Adductor Digiti Minimi in Elective Surgery Patients

NCT04524585Not ApplicableRecruiting

Partial Neuromuscular Blockade in Acute Hypoxemic Respiratory Failure

NCT05471882Active Not Recruiting

Predicting Neuromuscular Recovery in Surgical Patients Using Machine Learning

NCT03605225Not ApplicableCompletedPrimary

Development and Validation of an Android-based Application for Anaesthesia Neuromuscular Monitoring

NCT04048655Not ApplicableActive Not RecruitingPrimary

Reversal of Neuromuscular Blockade During the General Anaesthesia

NCT05661409Phase 4CompletedPrimary

Sugammadex as Rescue Therapy

NCT06409260Not ApplicableRecruitingPrimary

Neuromuscular Monitoring in Children (6 Months - 2 Years) With Electromyography and Acceleromyography

NCT04609410Not ApplicableTerminatedPrimary

Bleeding in Laparoscopic Liver Surgery

Scroll to load more

Research Network

Activity Timeline